HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EPA endocrine disruptors review

This article was originally published in The Rose Sheet

Executive Summary

Agency's Endocrine Disruptor Methods Validation Subcommittee will meet Dec. 10-12 in Washington, D.C. to discuss next steps involved with validating Pubertal and Aromatase assays and receive introductory presentation on Adult Intact Male assay. Group also will receive updates on the Androgen Receptor Binding assay, efforts to finalize reference chemicals, the OECD Fish Drafting Group and activities regarding in vitro fish assays. EPA was directed by the 1996 Food Quality Protection Act to develop a screening program to assess whether certain substances have hormonal effects in humans...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS011714

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel